Our nationally ranked doctors are experts in clinical research and design. For us, staying at the forefront of cancer treatment means we develop innovative strategies that give us new insights about cancer. For you, being at the forefront of cancer care means access to these novel treatments and knowledge.
Fox Chase’s Clinical Research Enterprise is geared for precision. Clinical studies are designed to enhance and complement ongoing advancements in the understanding of cancer. These efforts drive what is commonly referred to as personalized medicine. Increasingly sophisticated treatments use this information to target specific oncology targets or biomarkers. Traditionally, clinical research programs relied on a more generalized approach. Treatments were trialed for specific therapeutic areas. The potential of increasingly targeted, precision medicine is moving beyond that approach by using a person’s own biological makeup to grant access to cutting edge research, while also minimizing exposure for patients to trials that do not match their biology.